메뉴 건너뛰기




Volumn 118, Issue 19-20, 2006, Pages 601-609

Urokinase-type plasminogen activator and its inhibitor in thyroid neoplasms: A cytosol study

Author keywords

Enzyme linked immunosorbent assay; Prognosis; Thyroid cancer; Type 1 plasminogen activator inhibitor; Urokinase type plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; UROKINASE;

EID: 33846305771     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00508-006-0703-1     Document Type: Article
Times cited : (22)

References (36)
  • 1
    • 0019988248 scopus 로고
    • Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer
    • Clark OH (1982) Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg 196: 361-370
    • (1982) Ann Surg , vol.196 , pp. 361-370
    • Clark, O.H.1
  • 2
    • 0032535770 scopus 로고    scopus 로고
    • A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the USA, 1985-1995
    • Hundahl SA, Fleming ID, Fremgen AM (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the USA, 1985-1995. Cancer 83: 2638-2648
    • (1998) Cancer , vol.83 , pp. 2638-2648
    • Hundahl, S.A.1    Fleming, I.D.2    Fremgen, A.M.3
  • 3
    • 1642392071 scopus 로고    scopus 로고
    • Implications of prognostic factors and risk groups in the managment of differentiated thyroid cancer
    • Shaha AR (2004) Implications of prognostic factors and risk groups in the managment of differentiated thyroid cancer. Laryngoscope 114: 393-402
    • (2004) Laryngoscope , vol.114 , pp. 393-402
    • Shaha, A.R.1
  • 4
    • 0030788411 scopus 로고    scopus 로고
    • The urokinase-type plasminogen activator system in cancer metastasis: A review
    • Andreasen PA, Kjöller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22
    • (1997) Int J Cancer , vol.72 , pp. 1-22
    • Andreasen, P.A.1    Kjöller, L.2    Christensen, L.3    Duffy, M.J.4
  • 5
    • 0019850184 scopus 로고
    • Effect of plasminogen activator (urokinase), plasmin, and thrombin on glucoprotein and collagenous components of basement membrane
    • Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Gabrisa BM (1981) Effect of plasminogen activator (urokinase), plasmin, and thrombin on glucoprotein and collagenous components of basement membrane. Cancer Res 41: 4629-4636
    • (1981) Cancer Res , vol.41 , pp. 4629-4636
    • Liotta, L.A.1    Goldfarb, R.H.2    Brundage, R.3    Siegal, G.P.4    Terranova, V.5    Gabrisa, B.M.6
  • 8
    • 0032882381 scopus 로고    scopus 로고
    • Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: Role of the plasmin activation sytem
    • Smit JW, van der Pluijm G, Romijn HA, Lowik CW, Morreau H, Goslings BM (1999) Degradation of extracellular matrix by metastatic follicular thyroid carcinoma cell lines: role of the plasmin activation sytem. Thyroid 9: 913-919
    • (1999) Thyroid , vol.9 , pp. 913-919
    • Smit, J.W.1    van der Pluijm, G.2    Romijn, H.A.3    Lowik, C.W.4    Morreau, H.5    Goslings, B.M.6
  • 9
    • 0029870599 scopus 로고    scopus 로고
    • Plasminogen activation system is active even in thyroid tumors: An immunohistochemical study
    • Ito Y, Takeda T, Kobayashi T, Wakasugi E, Tamaki Y, Umeshita K, et al (1996) Plasminogen activation system is active even in thyroid tumors: An immunohistochemical study. Anticancer Res 16: 81-90
    • (1996) Anticancer Res , vol.16 , pp. 81-90
    • Ito, Y.1    Takeda, T.2    Kobayashi, T.3    Wakasugi, E.4    Tamaki, Y.5    Umeshita, K.6
  • 10
    • 0019083094 scopus 로고
    • Breast Cancer Cooperative Group Revision of the standards for the assessment of hormone receptors in human breast cancer
    • EORTC
    • EORTC (1980) Breast Cancer Cooperative Group Revision of the standards for the assessment of hormone receptors in human breast cancer. Eur J Cancer 16: 1513-1515
    • (1980) Eur J Cancer , vol.16 , pp. 1513-1515
  • 11
    • 0028358771 scopus 로고
    • Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1
    • Jänicke F, Pache L, Schmitt M, Ulm K, Thomssen C, Prechtl A, Graeff H (1994) Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1. Cancer Res 54: 2527-2530
    • (1994) Cancer Res , vol.54 , pp. 2527-2530
    • Jänicke, F.1    Pache, L.2    Schmitt, M.3    Ulm, K.4    Thomssen, C.5    Prechtl, A.6    Graeff, H.7
  • 12
    • 0034041973 scopus 로고    scopus 로고
    • Thyroid cancer: Extent of thyroidectomy
    • Shaha AR (2000) Thyroid cancer: Extent of thyroidectomy. Cancer Control 7: 240-245
    • (2000) Cancer Control , vol.7 , pp. 240-245
    • Shaha, A.R.1
  • 13
    • 0021669783 scopus 로고
    • Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy
    • Cohn KH, Backdahl M, Forsslund G (1984) Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96: 957-991
    • (1984) Surgery , vol.96 , pp. 957-991
    • Cohn, K.H.1    Backdahl, M.2    Forsslund, G.3
  • 14
    • 4444266968 scopus 로고    scopus 로고
    • AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States
    • Haigh PI, Urbach DR, Rotstein LE (2004) AMES prognostic index and extent of thyroidectomy for well-differentiated thyroid cancer in the United States. Surgery 136: 609-616
    • (2004) Surgery , vol.136 , pp. 609-616
    • Haigh, P.I.1    Urbach, D.R.2    Rotstein, L.E.3
  • 15
    • 0018648251 scopus 로고
    • A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group
    • Byar DP, Green SB, Dor P (1979) A prognostic index for thyroid carcinoma: A study of the EORTC Thyroid Cancer Cooperative Group. Eur J Cancer 15: 1033-1041
    • (1979) Eur J Cancer , vol.15 , pp. 1033-1041
    • Byar, D.P.1    Green, S.B.2    Dor, P.3
  • 16
    • 0023521529 scopus 로고
    • Ispilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system
    • Hay ID, Grant CS, Taylor WF (1987) Ispilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102: 1088-1095
    • (1987) Surgery , vol.102 , pp. 1088-1095
    • Hay, I.D.1    Grant, C.S.2    Taylor, W.F.3
  • 17
    • 0027135424 scopus 로고
    • Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989
    • Hay ID, Bergstrahl EJ, Goellner JR (1993) Predicting outcome in papillary thyroid carcinoma: Development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058
    • (1993) Surgery , vol.114 , pp. 1050-1058
    • Hay, I.D.1    Bergstrahl, E.J.2    Goellner, J.R.3
  • 18
    • 3042826468 scopus 로고    scopus 로고
    • Prognostic Scoring systems in patients with follicular thyroid cancer: A comparison of different staging systems in predicting the patient outcome
    • D'Avanzo A, Ituarte P, Treseler P, Kebebew E, Wong JM, Duh QY, Siperstein AE, Clark OH (2004) Prognostic Scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. Thyroid 14: 453-458
    • (2004) Thyroid , vol.14 , pp. 453-458
    • D'Avanzo, A.1    Ituarte, P.2    Treseler, P.3    Kebebew, E.4    Wong, J.M.5    Duh, Q.Y.6    Siperstein, A.E.7    Clark, O.H.8
  • 19
    • 0034080079 scopus 로고    scopus 로고
    • Prognostic Indicators in differentiated thyroid carcinoma
    • Dean DS, Hay ID (2000) Prognostic Indicators in differentiated thyroid carcinoma. Cancer Control 7: 229-239
    • (2000) Cancer Control , vol.7 , pp. 229-239
    • Dean, D.S.1    Hay, I.D.2
  • 20
    • 0031028402 scopus 로고    scopus 로고
    • Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and results (SEER) program, 1973-1991
    • Gilland FD, Hunt WC, Morris DM (1997) Prognostic factors for thyroid carcinoma: a population-based study of 15,698 cases from the Surveillance, Epidemiology and results (SEER) program, 1973-1991. Cancer 79: 564-573
    • (1997) Cancer , vol.79 , pp. 564-573
    • Gilland, F.D.1    Hunt, W.C.2    Morris, D.M.3
  • 22
    • 0027943619 scopus 로고
    • Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
    • Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418-428
    • (1994) Am J Med , vol.97 , pp. 418-428
    • Mazzaferri, E.L.1    Jhiang, S.M.2
  • 24
    • 0033968403 scopus 로고    scopus 로고
    • The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients
    • Foekens JA, Peters HA, Look MP, Portengen H, Schmitt M, Kramer M, et al (2000) The urokinase system of plasminogen activation and prognosis in 2,780 breast cancer patients. Cancer Res 60: 636-643
    • (2000) Cancer Res , vol.60 , pp. 636-643
    • Foekens, J.A.1    Peters, H.A.2    Look, M.P.3    Portengen, H.4    Schmitt, M.5    Kramer, M.6
  • 25
    • 0024428950 scopus 로고
    • Urokinase-type plasminogen activator antigen and early relapse in breast cancer
    • Jänicke F, Schmitt M, Ulm K, Gossner W, Graeff H (1989) Urokinase-type plasminogen activator antigen and early relapse in breast cancer. Lancet 2: 1049
    • (1989) Lancet , vol.2 , pp. 1049
    • Jänicke, F.1    Schmitt, M.2    Ulm, K.3    Gossner, W.4    Graeff, H.5
  • 26
    • 1842296358 scopus 로고    scopus 로고
    • High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma
    • Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS (1997) High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma. Cancer 79: 878-883
    • (1997) Cancer , vol.79 , pp. 878-883
    • Cho, J.Y.1    Chung, H.C.2    Noh, S.H.3    Roh, J.K.4    Min, J.S.5    Kim, B.S.6
  • 27
    • 0028070859 scopus 로고
    • Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamos and large cell lung cancer tissue
    • Pedersen H, Brunner N, Francis D, Osterlind K, Ronne E, Hansen HH, et al (1994) Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamos and large cell lung cancer tissue. Cancer Res 54: 4671-4675
    • (1994) Cancer Res , vol.54 , pp. 4671-4675
    • Pedersen, H.1    Brunner, N.2    Francis, D.3    Osterlind, K.4    Ronne, E.5    Hansen, H.H.6
  • 28
    • 0027935805 scopus 로고
    • Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer
    • Ganesh S, Sier CF, Griffioen G, Vloedgraven HJ, de Boer A, Welvaart K, et al (1994) Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res 54: 4065-4071
    • (1994) Cancer Res , vol.54 , pp. 4065-4071
    • Ganesh, S.1    Sier, C.F.2    Griffioen, G.3    Vloedgraven, H.J.4    de Boer, A.5    Welvaart, K.6
  • 29
    • 0029898212 scopus 로고    scopus 로고
    • Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma
    • Hofmann R, Lehmer A, Buresh M, Hartung R, Ulm K (1996) Clinical relevance of urokinase plasminogen activator, its receptor, and its inhibitor in patients with renal cell carcinoma. Cancer (Phila) 78: 487-492
    • (1996) Cancer (Phila) , vol.78 , pp. 487-492
    • Hofmann, R.1    Lehmer, A.2    Buresh, M.3    Hartung, R.4    Ulm, K.5
  • 30
    • 0033055316 scopus 로고    scopus 로고
    • Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
    • Kuhn W, Schalfeldt B, Reuning U, Pache L, Berger U, Ulm K, et al (1999) Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc. Br J Cancer 79: 1746-1751
    • (1999) Br J Cancer , vol.79 , pp. 1746-1751
    • Kuhn, W.1    Schalfeldt, B.2    Reuning, U.3    Pache, L.4    Berger, U.5    Ulm, K.6
  • 31
    • 0032520105 scopus 로고    scopus 로고
    • Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma
    • Nakanishi K, Kawai T, Torikata C, Aurues T, Ikeda T (1998) Urokinase-type plasminogen activator, its inhibitor, and its receptor in patients with upper urinary tract carcinoma. Cancer 82: 724-732
    • (1998) Cancer , vol.82 , pp. 724-732
    • Nakanishi, K.1    Kawai, T.2    Torikata, C.3    Aurues, T.4    Ikeda, T.5
  • 32
    • 0028639208 scopus 로고
    • Impact of urokinase type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus
    • Kobayashi H, Fujishiro S, Terao T (1994) Impact of urokinase type plasminogen activator and its inhibitor type 1 on prognosis in cervical cancer of the uterus. Cancer Res 54: 6539-6548
    • (1994) Cancer Res , vol.54 , pp. 6539-6548
    • Kobayashi, H.1    Fujishiro, S.2    Terao, T.3
  • 34
    • 9244231807 scopus 로고    scopus 로고
    • Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis
    • Chu QD, Hurd TC, Harvey S, Martinick M, Markus G, Tan D, et al (2004) Overexpression of urinary plasminogen activator (uPA) protein and mRNA in thyroid carcinogenesis. Diagn Mol Pathol 13: 241-246
    • (2004) Diagn Mol Pathol , vol.13 , pp. 241-246
    • Chu, Q.D.1    Hurd, T.C.2    Harvey, S.3    Martinick, M.4    Markus, G.5    Tan, D.6
  • 36
    • 0025128311 scopus 로고    scopus 로고
    • Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 546-576.1984) Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96: 957-991
    • Hay ID (1990) Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 19: 546-576.1984) Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 96: 957-991


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.